Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Gaithersburg, MD, US. The stock last traded at $3.49, down 10.51% on the session, giving a market capitalisation of $16.6M. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of 0.0%. Its beta of 1.14 implies it has historically moved more than the broad market.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Shuttle Pharmaceuticals Holdings, Inc. is most often compared with the following Healthcare names: